Abstract

BackgroundPrevious studies focused on the relationship between body mass index and cognitive disorder and obtained many conflicting results. This study explored the potential effects of body mass index on the risk of mild cognitive impairment (amnestic and non-amnestic) in the elderly.MethodsThe study enrolled 240 amnestic mild cognitive impairment patients, 240 non-amnestic mild cognitive impairment patients and 480 normal cognitive function controls. Data on admission and retrospective data at baseline (6 years ago) were collected from their medical records. Cognitive function was evaluated using Mini-Mental State Examination and Montreal Cognitive Assessment.ResultsBeing underweight, overweight or obese at baseline was associated with an increased risk of amnestic mild cognitive impairment (OR: 2.30, 95%CI: 1.50 ~ 3.52; OR: 1.74, 95%CI: 1.36 ~ 2.20; OR: 1.71, 95%CI: 1.32 ~ 2.22, respectively). Being overweight or obese at baseline was also associated with an increased risk of non-amnestic mild cognitive impairment (OR: 1.51, 95%CI: 1.20 ~ 1.92; OR: 1.52, 95%CI: 1.21 ~ 1.97, respectively). In subjects with normal weights at baseline, an increased or decreased body mass index at follow-up was associated with an elevated risk of amnestic mild cognitive impairment (OR: 1.80, 95%CI: 1.10 ~ 3.05; OR: 3.96, 95%CI: 2.88 ~ 5.49, respectively), but only an increased body mass index was associated with an elevated risk of non-amnestic mild cognitive impairment (OR: 1.71, 95%CI: 1.16 ~ 2.59).ConclusionsUnhealthy body mass index levels at baseline and follow-up might impact the risk of both types of mild cognitive impairment (amnestic and non-amnestic).

Highlights

  • Previous studies focused on the relationship between body mass index and cognitive disorder and obtained many conflicting results

  • We conducted a retrospective observational study enrolling nearly 1000 subjects to clarify the potential effects of baseline disorder and the follow-up changes of body mass index (BMI) on the risk of amnestic mild cognitive impairment (MCI) (aMCI) and non-amnestic MCI (naMCI) in elderly people

  • Metformin and statins in the aMCI and naMCI groups compared with the control group (P < 0.05)

Read more

Summary

Methods

Subjects Tianjin Medical University General Hospital Geriatrics Department provides medical services to the elderly in the district. The inclusion criteria for MCI patients were predefined as follows: (1) Outpatients in Geriatrics Department, Tianjin Medical University General Hospital between January 1, 2014, and October 31, 2016, (2) over 60 years of age on admission, (3) meet the diagnostic criteria of aMCI or naMCI. A total of 480 controls with normal cognitive function were randomly selected from the Medical Examination Department, Tianjin Medical University General Hospital in the same period. The study was approved by the Ethics Committee of Tianjin Medical University General Hospital Data collection This was a retrospective observational study. All analyses were conducted using SPSS version 19.0 (SPSS, iNC., Chicago, IL, USA)

Results
Background
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call